RESUMO
This paper presents the experimental results obtained after incorporating the recovered Carbon Black (rCB) produced in an industrial-scale waste tire pyrolysis plant into a Natural Rubber (NR) formulation. The purpose of this study is to increase the technical knowledge on the use of rCB as a sustainable raw material in the rubber industry. The rCB and virgin Carbon Black (vCB) (ref. N550) under study were characterized using elemental and proximate analyses, X-Ray Fluorescence (XRF), Fourier Transform Infrared (FTIR) spectroscopy, and Scanning Electron Microscopy (SEM) were used, and different measures, including the Brunauer-Emmett-Teller (BET) surface area (SBET), particle size distribution (PSD), specific gravity, and pH, were estimated. The effect of rCB incorporation on the rheological, thermal, structural, and mechanical properties of the NR composites was assessed and compared to those obtained with vCB alone. The NR composites were prepared using different loads of vCB (20, 30, 40, and 50 phr), which was also replaced with rCB at different proportions (0, 50, and 100%). According to the characterization results, rCB offers lower reinforcement properties than vCB, which is attributable to its higher volatile matter and ash contents, higher apparent PSD, lower presence of acidic functional groups, and lower SBET. Despite this, interesting performances can be achieved when rCB is partially incorporated into the formulations or by increasing its load in the composites. For instance, when 50% of vCB was replaced with rCB, the values of the aforementioned properties were found to be between those obtained with the NR composites prepared with vCB and rCB. In addition, when increasing the rCB loading, some properties matched the behavior exhibited by vCB alone, thus compensating for the low reinforcement properties of rCB. These results are expected to provide an important impetus to move towards circular economy strategies having very positive impacts from the sustainable perspective.
Assuntos
Pirólise , Fuligem , Carbono , Resíduos Industriais , BorrachaRESUMO
In Latin America, the cultivation of Arabica coffee (Coffea arabica) plays a critical role in rural livelihoods, biodiversity conservation, and sustainable development. Over the last 20 years, coffee farms and landscapes across the region have undergone rapid and profound biophysical changes in response to low coffee prices, changing climatic conditions, severe plant pathogen outbreaks, and other drivers. Although these biophysical transformations are pervasive and affect millions of rural livelihoods, there is limited information on the types, location, and extent of landscape changes and their socioeconomic and ecological consequences. Here we review the state of knowledge on the ongoing biophysical changes in coffee-growing regions, explore the potential socioeconomic and ecological impacts of these changes, and highlight key research gaps. We identify seven major land-use trends which are affecting the sustainability of coffee-growing regions across Latin America in different ways. These trends include (1) the widespread shift to disease-resistant cultivars, (2) the conventional intensification of coffee management with greater planting densities, greater use of agrochemicals and less shade, (3) the conversion of coffee to other agricultural land uses, (4) the introduction of Robusta coffee (Coffea canephora) into areas not previously cultivated with coffee, (5) the expansion of coffee into forested areas, (6) the urbanization of coffee landscapes, and (7) the increase in the area of coffee produced under voluntary sustainability standards. Our review highlights the incomplete and scattered information on the drivers, patterns, and outcomes of biophysical changes in coffee landscapes, and lays out a detailed research agenda to address these research gaps and elucidate the effects of different landscape trajectories on rural livelihoods, biodiversity conservation, and other aspects of sustainable development. A better understanding of the drivers, patterns, and consequences of changes in coffee landscapes is vital for informing the design of policies, programs, and incentives for sustainable coffee production. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13593-021-00712-0.
RESUMO
Additive manufacturing (AM) is a relatively new option in mold manufacturing for rapid tooling (RT) in injection processes. This paper presents the results of experiments with mold inserts and specimens obtained by stereolithography (SLA), which is a kind of AM. A mold insert obtained by AM and a mold produced by traditional subtractive manufacturing were compared to evaluate the performance of the injected parts. In particular, mechanical tests (in accordance with ASTM D638) and temperature distribution performance tests were carried out. The tensile test results of specimens obtained in a 3D printed mold insert were better (almost 15%) than those produced in the duralumin mold. The simulated temperature distribution closely matched its experimental counterpart-the difference in average temperatures was merely 5.36 °C. These findings support the use of AM in injection molding and RT as an excellent alternative for small and medium-sized production runs in the global injection industry.
RESUMO
Injection molds are production tools that require detailed analysis based on the quality of the resulting part, the impact on cycle times, and the expected production volume. Cooling channels also play a critical role in mold performance and product quality as they largely determine cycle time. Designs that incorporate conformal cooling channel (CCC) geometries that conform to or align with the part contour are currently being explored as an alternative to conventional cooling channel designs in injection molds. In this study, a simulation of CCC geometries was performed and their effects on mold temperatures and warpage were investigated. Two cross-sectional geometries, circular and square, were selected for a three-factor level design of experiments (DOE) analysis. The response variables used were mold temperatures and part warpage. A cup-shaped part with upper and lower diameters of 54 and 48 mm, respectively, a height of 23 mm and a thickness of 3 mm was used for the injection molded part. A comparison was also made between two materials for the injection mold, steel and polycarbonate. The DOE results showed that the distance between the CCC and the injected part and the diameter or side of the square have significant effects on the response variables for both systems (steel and polycarbonate molds). In addition, a comparison between conventional and conformal cooling channels was analyzed using a cup-shaped part and a less rigid part geometry. The finite element simulation results show a 9.26% reduction in final warpage in the cup-shaped part using CCCs compared with the conventional cooling methods in steel. When using parts with lower geometry stiffness, the use of CCCs reduced final part warpage by 32.4% in metal molds and by 59.8% in polymer molds.
RESUMO
Methadone treatment reduces the use of heroin and withdrawal symptoms; however, methadone is an expensive medication with a narrow safety margin. We compared the retention rates, persistence of heroin use, and quality of life of a group of patients undergoing conventional Methadone Maintenance Treatment (MMT) with a group for whom the CYP2B6 516G>T polymorphism was used in addition to the MMT to calculate the required methadone dose. Over 12 weeks, the retention rate, heroin usage, and quality of life of patients under conventional treatment (n = 34) were compared with those of patients for whom we used genetic markers to calculate methadone dosage (n = 38). At the end of the study, 26.4% of patients abandoned the program, and neither demographic nor clinical variables were associated with treatment adherence. Of the remaining patients, 16% of the control group and 8% of patients in the pharmacogenetic group reported heroin use, while both groups showed a 64% reduction in the use of cocaine/crack (no significant differences between the groups were found). Starting in the second week, the methadone dosage was lower among the patients for whom methadone was prescribed based on genotype. Although there were six individuals in the control group and three in the pharmacogenetic group with QTc intervals > 450 ms (a threshold that is considered dangerous), we did not find a relationship between the QTc interval and methadone dosage. There were no differences in the perception of quality of life between the two groups. The results of this pilot study suggest that concerning methadone therapy, the CYP2B6 genotype contributes to reduced effective doses and treatment costs.
RESUMO
Background and Objective: Neurological insults during surgery arise from anatomic and/or physiologic perturbations. Intraoperative neurophysiologic monitoring (IONM) fills a critical role of ensuring that any neurological insults during certain surgical procedures are caught in real-time to prevent patient harm. IONM provides immediate feedback to the surgeon and anesthesiologist about the need for an intervention to prevent a neurologic deficit postoperatively. As important as it seems to have IONM available to any patient having surgery where a neurological injury is possible, the truth is that IONM is unavailable to large swaths of people around the world. This review is intended to bring attention to all of the ways IONM is critically important for a variety of surgeries and highlight the barriers preventing most patients around the world from benefiting from the technology. Expansion of IONM to benefit patients from all over the world is the new frontier. Methods: We searched all English language original papers and reviews using Embase and MEDLINE/PubMed databases published from 1995 to 2022. Different combinations of the following search terms were used: intraoperative neuromonitoring, neurosurgery, low-income countries, cost, safety, and efficacy. Key Content and Findings: We describe common IONM modalities used during surgery as well as explore barriers to implementation of IONM in resource-limited regions. Additionally, we describe ongoing efforts to establish IONM capabilities in new locations around the world. Conclusions: In this paper, we performed a review of the literature on IONM with an emphasis on the basic understanding of clinical applications and the barriers for expansion into resource-limited settings. Finally, we provide our interpretation of "new frontiers" in IONM quite literally facilitating access to the tools and education so a hospital in Sub-Saharan Africa can incorporate IONM for their high-risk surgeries.
RESUMO
The degree of quality of thermoplastic injection-molded parts can be established based on their weight, appearance, and defects. However, the conditions of the injection process may induce effects on the mechanical performance of the injected parts, and the residual stresses can cause cracks or early failures when an external load or force is applied. To evaluate these mechanical behaviors, different experimental techniques have been reported in the literature, where digital photoelasticity has stood out both for being a non-contact technique and for achieving quantitative results through sophisticated computational algorithms. Against this background, our proposal consists of analyzing the overall residual stress distribution of parts injected under different molding conditions by using digital photoelasticity. In this case, the specimens are subjected to bending strength tests to identify possible effects of the injection process conditions. The findings show that, at mold temperatures of 80 °C, flow-induced residual stresses increase with packing pressure. However, these internal stress levels do not affect the external load applied by the mechanical bending test, while the mass injected at higher levels of packing pressure helps to increase the bending strength of the injected part. At lower mold temperatures (50 °C), the mechanical strength of the injected part is slightly reduced, possibly due to a lower effect of the packing pressure.
RESUMO
The currently growing demand for metallic and polymeric products has undoubtedly changed the rules of manufacturing, enabling customers to more functionally define their products based on their needs. Nowadays, a new technique for rapid tooling, Additive Manufacturing (AM), can create customized products with more complex geometries and short life cycles (flexibility) in order to keep up with the new variables imposed by the manufacturing environment. In the last two decades, the migration from subtractive manufacturing to AM has materialized such products with reduced costs and cycle times. AM has been recently promoted to develop polymer molds for product manufacturing. This paper reviews the main findings in the literature concerning polymer molds created by AM compared to conventional (metal) molds obtained by subtractive manufacturing. Information about specific topics is scarce or nonexistent, for example, about the characterization of the most commonly injected materials and molds used in this type of technology, their mechanical properties (part and mold), designs for all types of geometries, and costs. These aspects are addressed in this literature review, highlighting the advantages of this alternative manufacturing process, which is considered a desirable technology worldwide.
RESUMO
A 4-year-old Colombian Creole mare was presented for diagnosis because the external orifice of her cervix was not detectable when a uterine lavage as therapy for uterine fluid accumulation was attempted. Clinical and ultrasonographic evaluation of the genital tract revealed that ovaries were of normal size and showed structures suggestive of regular ovarian activity. However, granular free-floating fluid material distending the uterus was detected by ultrasound. Upon vaginal examination, the normal external cervical morphology was not evident. The vagina ended in a blind bag with a small papilla with no evident external cervical os. Cytology of uterine fluid obtained by transvaginal aspiration showed findings compatible with mucometra. Cytogenetic analysis revealed an abnormal karyotype (63,X and 64,XX both 45% and 65,XXX 10%). A diagnosis of congenital segmental cervical aplasia was proposed possibly related to the mosaicism detected. To our knowledge, this is the first case of this reproductive pathology in a mare with regular ovarian activity and confirmed aneuploidy in mosaic form of the X sex chromosome.
Assuntos
Doenças dos Cavalos , Útero , Aneuploidia , Animais , Colômbia , Feminino , Cavalos , Mosaicismo , Cromossomo XRESUMO
The cytochrome P450 (CYP)4F2 gene is known to influence mean coumarin dose. The aim of the present study was to undertake a meta-analysis at the individual patients level to capture the possible effect of ethnicity, gene-gene interaction, or other drugs on the association and to verify if inclusion of CYP4F2*3 variant into dosing algorithms improves the prediction of mean coumarin dose. We asked the authors of our previous meta-analysis (30 articles) and of 38 new articles retrieved by a systematic review to send us individual patients' data. The final collection consists of 15,754 patients split into a derivation and validation cohort. The CYP4F2*3 polymorphism was consistently associated with an increase in mean coumarin dose (+9% (95% confidence interval (CI) 7-10%), with a higher effect in women, in patients taking acenocoumarol, and in white patients. The inclusion of the CYP4F2*3 in dosing algorithms slightly improved the prediction of stable coumarin dose. New pharmacogenetic equations potentially useful for clinical practice were derived.
Assuntos
Cumarínicos/administração & dosagem , Citocromo P-450 CYP2C9/genética , Família 4 do Citocromo P450/genética , Polimorfismo de Nucleotídeo Único/genética , Vitamina K Epóxido Redutases/genética , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Cumarínicos/efeitos adversos , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
BACKGROUND: Omeprazole is metabolized by the hepatic cytochrome P450 (CYP) 2C19 enzyme to 5-hydroxyomeprazole. CYP2C19 exhibits genetic polymorphisms responsible for the presence of poor metabolizers (PMs), intermediate metabolizers (IMs) and extensive metabolizers (EMs). The defective mutations of the enzyme and their frequencies change between different ethnic groups; however, the polymorphism of the CYP2C19 gene has not been studied in Colombian mestizos. The aim of this study was to evaluate the genotype and phenotype status of CYP2C19 in Colombian mestizos, in order to contribute to the use of appropriate strategies of drug therapy for this population. METHODS: 189 subjects were genotyped using the multiplex SNaPshot technique and a subgroup of 44 individuals received 20 mg of omeprazole followed by blood collection at 3 hours to determine the omeprazole hydroxylation index by HPLC. RESULTS: 83.6%, 15.3% and 1.1% of the subjects were genotyped as EMs, IMs and PMs, respectively. The frequencies of the CYP2C29*1 and CYP2C19*2 alleles were 91.3% and 8.7% respectively whereas the *3, *4, *5, *6 and *8 alleles were not found. No discrepancies were found between the genotype and phenotype of CYP2C19. CONCLUSION: The frequency of poor metabolizers (1.1%) in the Colombian mestizos included in this study is similar to that in Bolivian mestizos (1%) but lower than in Mexican-Americans (3.2%), West Mexicans (6%), Caucasians (5%) and African Americans (5.4%). The results of this study will be useful for drug dosage recommendations in Colombian mestizos.
Assuntos
2-Piridinilmetilsulfinilbenzimidazóis/farmacocinética , Indígena Americano ou Nativo do Alasca/genética , Antiulcerosos/farmacocinética , Hidrocarboneto de Aril Hidroxilases/genética , Genética Populacional , Fígado/enzimologia , Oxigenases de Função Mista/genética , Omeprazol/farmacocinética , Polimorfismo Genético , 2-Piridinilmetilsulfinilbenzimidazóis/sangue , Administração Oral , Adulto , Antiulcerosos/administração & dosagem , Antiulcerosos/sangue , Hidrocarboneto de Aril Hidroxilases/metabolismo , Biotransformação , Cromatografia Líquida de Alta Pressão , Colômbia , Citocromo P-450 CYP2C19 , Feminino , Frequência do Gene , Genótipo , Humanos , Hidroxilação , Masculino , Pessoa de Meia-Idade , Oxigenases de Função Mista/metabolismo , Omeprazol/administração & dosagem , Omeprazol/sangue , FenótipoRESUMO
Polymorphisms Arg(16)Gly and Gln(27)Glu of the gene of adrenoreceptor beta(2)(ADRB2) are associated with altered sympathetic responses. This study evaluated the relationship between these polymorphisms and changes in lipids induced by metoprolol in hypertensive patients. 105 adults were enrolled. After serum lipid levels and genotype had been determined, metoprolol was administered orally. Genotyping was performed using a mini-sequencing technique. Allelic and genotypic frequencies were: Arg(16) (49.5%); Gly(16) (50.5%); Gln(27) (89%); Glu(27) (11%); Arg(16)Arg (28.6%); Arg(16)Gly (41.9%); Gly(16)Gly (29.5%); Gln(27)Gln (81%); Gln(27)Glu (16.1%), and Glu(27)Glu (2.9%). Ninety patients concluded the study. There were no significant differences between the demographic, pharmacological and biochemical variables evaluated, grouped by their genotype in positions 16 and 27 of the ADRB2 gene. We did not find differences in lipid profiles in the whole group, but when we compared these profiles within each genotypic subgroup, we found that total cholesterol diminished (p = 0.03) in the patients with the native Gln(27)Gln genotype, whereas in the Gln(27)Glu heterozygous triglycerides increased (p = 0.025). We only found 3 patients homozygous for Glu(27)Glu and 2 of them were treated with diet and antidyslipidemic drugs. These results suggest that the polymorphism of codon 27 constitutes the target of the changes in lipids induced by beta-adrenergic receptor antagonists.
Assuntos
Antagonistas Adrenérgicos beta/farmacologia , Lipídeos/sangue , Metoprolol/farmacologia , Polimorfismo Genético , Receptores Adrenérgicos beta 2/genética , Adulto , Idoso , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Resumen Los polímeros termoplásticos, pueden ser mezclados con diferentes tipos de cargas con el propósito de mejorar su rendimiento físico-mecánico, al mismo tiempo que permiten en muchos casos, generar soluciones a problemáticas ambientales como por ejemplo la disposición final de residuos de madera. Los compuestos de madera plástica son productos elaborados mediante la incorporación de fibras o partículas de madera en la matriz polimérica, donde la interacción entre los dos materiales (nula o con acople) es clave para lograr un adecuado desempeño del producto final. En esta revisión se establecen las matrices poliméricas y los tipos de maderas empleadas comúnmente en la elaboración de productos de madera plástica, al mismo tiempo que se definen los tratamientos previos que deben ser realizados tanto en la madera como en el polímero con el propósito de mejorar la compatibilidad de los dos materiales, y de esta manera mejorar propiedades como la absorción de agua, la resistencia a la descomposición, a la intemperie y el desempeño mecánico. En cuanto a las propiedades mecánicas, al adicionar un contenido de madera en el polímero se modifica la rigidez del material polimérico y la resistencia en tensión, flexión e impacto; sin embargo, se establece que es clave el uso de agentes funcionalizantes para que el efecto de la incorporación de la madera en polímero sea positivo. Finalmente se estudian las nuevas tendencias en el uso de diferentes tipos de residuos y matrices poliméricas para la elaboración de maderas plásticas.
Abstract Polymeric materials, especially thermoplastics, can be mixed with different types of fillers to improve their physical-mechanical performance, at the same time they allow, in many cases, to generate solutions to environmental problems such as the final disposal of wood waste. The plastic wood composites are products made by incorporating wood fibers in the polymer matrix, where the interaction between the two materials is key to achieve an adequate performance of the final product. This review establishes the polymer matrices and the types of wood commonly used in the production of plastic wood products, at the same time defining the previous treatments that must be carried out in the wood and in the polymer to improve the compatibility of the two materials, and in this way improve properties such as water absorption, resistance to decomposition, resistance to weathering and mechanical performance. Related to the mechanical properties, adding the wood fibers in the polymer modifies the rigidity of the polymeric material and the resistance in tension, bending and impact; however, it is established that the use of functionalizing agents is a fundamental key to improve the effect of wood incorporation into the polymer matrix. Finally, the new trends in the use of different types of waste and polymeric matrices to produce plastic wood are studied.
Resumo Os materiais poliméricos, principalmente os termoplásticos, podem ser misturados a diferentes tipos de cargas para melhorar seu desempenho físico-mecânico, ao mesmo tempo que, em muitos casos, permitem gerar soluções para problemas ambientais como a destinação final de resíduos. madeira. Os compósitos madeira-plástico são produtos obtidos pela incorporação de fibras de madeira à matriz polimérica, onde a interação entre os dois materiais é fundamental para um desempenho adequado do produto final. Nesta revisão, são estabelecidas as matrizes poliméricas e os tipos de madeira comumente utilizados na produção de produtos plásticos de madeira, ao mesmo tempo em que são definidos os tratamentos anteriores que devem ser realizados na madeira e no polímero para melhorar a compatibilidade dos dois materiais, e desta forma melhorar propriedades como absorção de água, resistência à decomposição, intempéries e desempenho mecânico. Em relação às propriedades mecânicas, ao adicionar as fibras de madeira ao polímero, a rigidez do material polimérico e a resistência à tração, flexão e impacto são modificadas; porém, está estabelecido que o uso de agentes funcionalizantes é fundamental para que o efeito da incorporação da madeira no polímero seja positivo. Por fim, são estudadas as novas tendências no uso de diferentes tipos de resíduos e matrizes poliméricas para a produção de madeira plástica.
Assuntos
Extubação/efeitos adversos , COVID-19/transmissão , Tosse/prevenção & controle , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Laringismo/prevenção & controle , Extubação/métodos , COVID-19/prevenção & controle , Criança , Humanos , Inalação , Posicionamento do Paciente/métodos , SARS-CoV-2RESUMO
In Colombian populations older than 15 years, 12.6% suffer from hypertensive disease. Pharmacological therapies for hypertension and associated diseases were compared for 11,947 adult hypertensive patients of both sexes. All had been in treatment for more than 3 months (November/01-January/02), and were distributed among six Colombian cities. The data were retrieved from medication consumption registers that were maintained by the institutions that distribute medications to patients selected for the study. The average age of patients was 55.8 +/- 13.8, and 67.7% were women. Men were older (p < 0.05) and consumed other drugs more than women (67.7% vs. 62.4%, p < 0.05); 53.2% of patients received only one drug and 46.8% received between 2 to 5 drugs for hypertension disease. Medications most commonly prescribed were hydrchlorothiazide (31.8%), captopril (27.9%), verapamil (27.6%), enalapril (25%), metoprolol (15.1%) and propranolol (14.9%). The most common combinations were hydrochlorothiazide + ACE inhibitors (n = 2,001), hydrochlorothiazide + calcium channel antagonists (n = 1,367), verapamil + ACE inhibitors (n = 1,153) and hydrochlorothiazide + beta blocker (n = 1,021). Other prescribed medications included ASA as antiplatelet (38.2% of patients), nonsteroidal anti-inflammatory drugs (NSAID, 16.2%), lipid-lowering drugs (11.8%), hypoglycemic agents (10.9%) and antiulcerous drugs (9.6%). Some agents are probably underemployed (ACE inhibitors, ASA) and others overused (antiulcerous). Potentially dangerous pharmacological interactions were discovered in 410 cases (3.43%). Significant differences occurred in physicians' formulations among the six cities, but rational prescription patterns prevailed. Newly designed educational strategies are recommended to prevent administration of potential harmful combinations. Further exploration of clinical results in these formulations is indicated.
Assuntos
Anti-Hipertensivos/uso terapêutico , Prescrições de Medicamentos/estatística & dados numéricos , Uso de Medicamentos/estatística & dados numéricos , Hipertensão/tratamento farmacológico , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Colômbia , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores SexuaisRESUMO
Hypertension represents a high health cost because of its prevalence, its low level of diagnosis and control, and its role as a primary risk factor for other cardiovascular diseases. According to the JNC 7 report, hypertensive individuals have blood pressures of 140/90 mm Hg or higher; recommended treatment reduces these values to below 120/80 mm Hg. Co-morbidity and the presence of other risk factors must also be considered. In a random sample of 458 hypertensive patients from 6 Colombian cities, the effectiveness, tolerance and adherence to treatment was compared in cases with treatment of at least one year's duration. During routine blood pressure examinations, trained nurses obtained patient consent and additional anthropometric data, such as including co-morbidity, risk factors, antihypertensive medication prescribed, dosages and usage of unrelated medications. Some of the data were retrieved from the patients' medical histories. The average age of the patients was 57.6 +/- 13 years, with 67.5% women; 92% with complete adherence to the treatment and 59% not reporting adverse events associated with the medication. Forty-four percent were treated with antihypertensive monotherapy with the most commonly prescribed medications as follows (in order): hydrochlorothiazide, verapamil, enalapril, metoprolol and propanolol. Forty-five percent (n=207) were control patients, 35% were in a hypertensive stage 1 and 19.7% were in stage 2. Multivariate analysis showed that uncontrolled hypertension was significantly associated with geriatrics receiving a combination of antihypertensive medication and residence in three cities--Ibagué, Barranquilla and Manizales--where smaller daily doses of hypertensive medications are prescribed. Health care teams are advised to adjust doses carefully to obtain clearly defined therapeutic objectives.
Assuntos
Anti-Hipertensivos/uso terapêutico , Hipertensão/tratamento farmacológico , Adulto , Idoso , Determinação da Pressão Arterial , Colômbia/epidemiologia , Quimioterapia Combinada , Feminino , Humanos , Hipertensão/diagnóstico , Hipertensão/epidemiologia , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Resultado do TratamentoRESUMO
BACKGROUND: Psychosocial care and methadone maintenance treatment (MMT) are the preferred strategies for the management of heroin addicts, but the results are still unsatisfactory, justifying the search and intervention of the factors influencing the response to treatment. METHODOLOGY: In order to determine the contribution of demographic, clinical and genetic variables on serum concentrations and response to methadone, we investigated patients on MMT, who were receiving methadone in supervised and unchanged doses at least during the previous two weeks. The age, gender, body mass index (BMI), duration of heroin abuse, addiction to other drugs, criminal background, current daily methadone doses, time spent in the TMM, comorbidity and concomitant medication were recorded. Blood samples were taken for the determination of serum levels of racemic methadone and its R and S-enantiomers, and for typing of candidate alleles of POR, CYP2B6, ABCB1, GRIN1, OPRM1, SLC6A3, DßH and ARRB2 genes, all associated with the metabolism, tissue distribution and mechanism of action of methadone. Methadone quantification was by HPLC-DAD, and the detection of genetic markers by Real Time PCR and VNTR methods. RESULTS: A total of 80 subject volunteers were enrolled, with a mean age of 23.5 (5) years (86% male), all of them were addicts of multiple drugs, 60% with a criminal background, 5.1 (2.9) years taking heroin, and 5.3 (4) months on MMT, and taking a supervised dose of 41 (12) mg/day methadone. The (R), (S) and (R, S) methadone enantiomer trough plasma levels were, 84 (40), 84 (42), and 168 (77) ng/mL, respectively. All genotypes were in Hardy-Weinberg equilibrium. The two urine tests were negative for heroin in 61.3% (49/80) of the volunteers, the decline in cocaine/crack use was 83%, 30% of marijuana, and other psychoactives (inhalants, benzodiazepines, amphetamines) decreased to zero, while the consumption of snuff remained at 93.5% (75/80). Blood concentrations of racemic methadone and its enantiomers were significantly associated with the dose/day of the medication, but none of the other demographic, clinical or genetic variables impacted on serum levels of methadone. As for the results of the MMT, non-users and occasional users of heroin, as well as those who stopped taking other psychoactive drugs, and the ones who did not, were similar as regards the demographic, genetic and clinical variables. This included the blood metahdone concentrations, except for individuals who did not reduce their consumption of other psychoactives other than heroin, who had significantly (P=.03) higher blood levels of S-methadone, compared with those who did stop taking them. CONCLUSIONS: There was a significant reduction in the consumption of heroin and other psychoactives, and social rehabilitation of patients. However, the extensive overlap between effective and ineffective doses of methadone suggests the presence of personal and social variables that transcend the simple pharmacological management. These probably need to be addressed more successfully from the psychosocial features, particularly as regards to identifying and overcoming relapse-trigger experiences, as well as certain features of the patient, such as their psychological distress level or their psychiatric disorders.
RESUMO
Pharmacogenetics and Pharmacogenomics areas are currently emerging fields focused to manage pharmacotherapy that may prevent undertreatment while avoiding associated drug toxicity in patients. Large international differences in the awareness and in the use of pharmacogenomic testing are presumed, but not well assessed to date. In the present study we review the awareness of Latin American scientific community about pharmacogenomic testing and the perceived barriers for their clinical application. In order to that, we have compiled information from 9 countries of the region using a structured survey which is compared with surveys previously performed in USA and Spain. The most relevant group of barriers was related to the need for clear guidelines for the use of pharmacogenomics in clinical practice, followed by insufficient awareness about pharmacogenomics among clinicians and the absence of regulatory institutions that facilitate the use of pharmacogenetic tests. The higher ranked pairs were TPMT/thioguanine, TPMT/azathioprine, CYP2C9/warfarin, UGT1A1/irinotecan, CYP2D6/amitriptiline, CYP2C19/citalopram and CYP2D6/clozapine. The lower ranked pairs were SLCO1B1/simvastatin, CYP2D6/metoprolol and GP6D/chloroquine. Compared with USA and Spanish surveys, 25 pairs were of lower importance for Latin American respondents. Only CYP2C19/esomeprazole, CYP2C19/omeprazole, CYP2C19/celecoxib and G6PD/dapsone were ranked higher or similarly to the USA and Spanish surveys. Integration of pharmacogenomics in clinical practice needs training of healthcare professionals and citizens, but in addition legal and regulatory guidelines and safeguards will be needed. We propose that the approach offered by pharmacogenomics should be incorporated into the decision-making plans in Latin America.
Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/genética , Testes Genéticos/métodos , Farmacogenética/métodos , Pesquisas sobre Atenção à Saúde , Humanos , América Latina , Guias de Prática Clínica como AssuntoRESUMO
Resumen Introducción. Se revisaron los fundamentos biológicos de la medicina regenerativa, en particular de las células madre y de los factores de crecimiento plaquetarios. Se presentan la clasificación, fuentes de obtención y mecanismos de acción propuestos para las células madre, así como los grandes desafíos biotecnológicos para el desarrollo de la medicina regenerativa y la evidencia clínica de su relación seguridad/efectividad en la práctica médica. Objetivo. Revisar y sistematizar la información actualizada acerca de los fundamentos y potenciales usos de la medicina regenerativa. Metodología. Se realizó una búsqueda sistemática de la literatura en las bases de datos Pubmed, Medline, Science y Cochrane, entre los años 2010 y el 2016, mediante las siguientes palabras clave: stem cells, mesenchymal stem cells, medicine regenerative, homing, platelet-rich plasma, platelet growth factors.
Abstract Introduction. We reviewed the biological fundaments of regenerative medicine, in particular of stem cells and the platelet growth factors. We presented the classification, sources of supply and proposed mechanisms of action for stem cells, as well as the great challenges of biotechnology for the development of regenerative medicine and the clinical evidence of its safety/efficacy relationship in medical practice. Objective. Review and systematize the updated information about the fundaments and potential uses of the regenerative medicine. Methodology. A systematic literature search was conducted in the Pubmed, Medline, Science and Cochrane databases, between 2010 and 2016, using the following key words: stem cells, mesenchymal stem cells, medicine regenerative, homing, platelet-rich plasma, platelet growth factors.